Get startedLog in
    Picture of Altamira Therapeutics logo

    CYTOF — Altamira Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Auris Medical Says Enrollment In First Part Of Travers Phase 2 Study Completed

    Picture of Altamira Therapeutics logoAltamira Therapeutics
    29/07/2020 13:53
    July 29 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES COMPLETION OF ENROLLMENT INTO
FIRST PART
OF TRAVERS PHASE 2 STUDY WITH AM-125 IN VERTIGO
    * AURIS MEDICAL HOLDING LTD - INTERIM RESULTS TO BE
ANNOUNCED IN
Q3 OF 2020

Source text for Eikon:  ID:nGNX90Kp3d 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Altamira Therapeutics

    See all news